Armata Pharmaceuticals (ARMP) Current Leases (2019 - 2026)
Armata Pharmaceuticals (ARMP) posted Current Leases of $4.6 million for Q1 2026, up 0.64% sequentially from $4.6 million in Q4 2025, and up 3.01% YoY from $4.5 million in Q1 2025.
Armata Pharmaceuticals (ARMP) Current Leases (2019 - 2026) Analysis & Trends
Armata Pharmaceuticals has reported Current Leases for 8 years, with the latest figure at $4.6 million in Q1 2026.
- Quarterly Current Leases rose 3.01% year-over-year to $4.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.6 million (up 3.01% YoY) and the FY2025 annual result came in at $4.6 million, up 3.0% from the prior year.
- Current Leases grew to $4.6 million in Q1 2026 per ARMP's latest filing, from $4.6 million in the prior quarter.
- Over five years, Current Leases peaked at $17.0 million in Q4 2022 and troughed at $1.5 million in Q1 2022.
- A 5-year average of $7.0 million and a median of $4.6 million in 2026 frame the typical range for Current Leases.
- The sharpest annual moves came in 2022 and 2024: Current Leases soared 1027.3% in 2022, then slumped 62.85% in 2024.
- Over 5 years, Current Leases stood at $17.0 million in 2022, then plunged by 44.27% to $9.5 million in 2023, then sank by 53.26% to $4.4 million in 2024, then grew by 3.0% to $4.6 million in 2025, then rose by 0.64% to $4.6 million in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $4.6 million, $4.6 million, and $4.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.65 Bn | 131.79 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.08 Bn | 78.09 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 65.16 Bn | 59.98 Bn | 1.37 Bn | - |
| 4 | Moderna | 63.25 Bn | 58.11 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.26 Bn | 27.95 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.96 Bn | 10.57 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.19 Bn | 26.35 Bn | - | - |
| 10 | Armata Pharmaceuticals | 165.92 Mn | 141.92 Mn | - | 4.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.62 Mn |
| Mar 31, 2026 | 4.59 Mn |
| Dec 31, 2025 | 4.56 Mn |
| Sep 30, 2025 | 4.53 Mn |
| Jun 30, 2025 | 4.49 Mn |
| Mar 31, 2025 | 4.46 Mn |
| Dec 31, 2024 | 4.43 Mn |
| Sep 30, 2024 | 4.99 Mn |
| Jun 30, 2024 | 6.60 Mn |
| Mar 31, 2024 | 7.50 Mn |
| Dec 31, 2023 | 9.48 Mn |
| Sep 30, 2023 | 13.44 Mn |
| Jun 30, 2023 | 14.53 Mn |
| Mar 31, 2023 | 13.10 Mn |
| Dec 31, 2022 | 17.01 Mn |
| Sep 30, 2022 | 2.22 Mn |
| Jun 30, 2022 | 1.71 Mn |
| Mar 31, 2022 | 1.52 Mn |
| Dec 31, 2021 | 1.51 Mn |
| Sep 30, 2021 | 1.73 Mn |